- Home
- PCSA vs FRGT Comparison
PCSA vs FRGT Comparison
Compare PCSA & FRGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCSA
- FRGT
- Stock Information
- Founded
- PCSA 2011
- FRGT 2015
- Country
- PCSA United States
- FRGT Mexico
- Employees
- PCSA N/A
- FRGT N/A
- Industry
- PCSA Biotechnology: Pharmaceutical Preparations
- FRGT Professional Services
- Sector
- PCSA Health Care
- FRGT Consumer Discretionary
- Exchange
- PCSA Nasdaq
- FRGT Nasdaq
- Market Cap
- PCSA 3.3M
- FRGT 3.5M
- IPO Year
- PCSA N/A
- FRGT N/A
- Fundamental
- Price
- PCSA $0.18
- FRGT $1.26
- Analyst Decision
- PCSA Strong Buy
- FRGT
- Analyst Count
- PCSA 1
- FRGT 0
- Target Price
- PCSA $1.00
- FRGT N/A
- AVG Volume (30 Days)
- PCSA 2.8M
- FRGT 145.9K
- Earning Date
- PCSA 10-29-2025
- FRGT 08-18-2025
- Dividend Yield
- PCSA N/A
- FRGT N/A
- EPS Growth
- PCSA N/A
- FRGT N/A
- EPS
- PCSA N/A
- FRGT N/A
- Revenue
- PCSA N/A
- FRGT $12,693,870.00
- Revenue This Year
- PCSA N/A
- FRGT $371.03
- Revenue Next Year
- PCSA N/A
- FRGT N/A
- P/E Ratio
- PCSA N/A
- FRGT N/A
- Revenue Growth
- PCSA N/A
- FRGT N/A
- 52 Week Low
- PCSA $0.15
- FRGT $1.15
- 52 Week High
- PCSA $1.50
- FRGT $23.31
- Technical
- Relative Strength Index (RSI)
- PCSA 34.36
- FRGT 40.72
- Support Level
- PCSA $0.16
- FRGT $1.16
- Resistance Level
- PCSA $0.23
- FRGT $1.50
- Average True Range (ATR)
- PCSA 0.02
- FRGT 0.11
- MACD
- PCSA -0.00
- FRGT 0.02
- Stochastic Oscillator
- PCSA 26.71
- FRGT 31.43
About PCSA Processa Pharmaceuticals Inc.
Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).
About FRGT Freight Technologies Inc.
Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.